Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM)

Background: Cost-of-Illness Analysis (COI) constitutes the basis for the decision-making process on the budget and allocation in a modern health care system. Considering the wide prevalence of type 2 diabetes mellitus (Т2DM), it is important to perform COI in the Russian Federation (RF). Aim: The a...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ivan I. Dedov, Marina F. Kalashnikova, Dmitriy Y. Belousov, Aleksey S. Kolbin, Vladimir V. Rafalskiy, Aleksey E. Cheberda, Mariya A. Kantemirova, Vadim D. Zakiev, Valentin V. Fadeyev
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2017
Materias:	type 2 diabetes mellitus pharmacoepidemiology analysis cost of illness direct medical costs direct non-medical costs indirect costs Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/539c7cdef59a4e00acef6e429a6d993f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:539c7cdef59a4e00acef6e429a6d993f
record_format	dspace
spelling	oai:doaj.org-article:539c7cdef59a4e00acef6e429a6d993f2021-11-14T09:00:21ZCost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM)2072-03512072-037810.14341/DM9278https://doaj.org/article/539c7cdef59a4e00acef6e429a6d993f2017-12-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/9278https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Background: Cost-of-Illness Analysis (COI) constitutes the basis for the decision-making process on the budget and allocation in a modern health care system. Considering the wide prevalence of type 2 diabetes mellitus (Т2DM), it is important to perform COI in the Russian Federation (RF). Aim: The aim of the secondary objective FORSIGHT-Т2DM study was to conduct Cost-of-Illness Analysis (COI) of Т2DM in the Russian Federation in relation to taking into consideration the presence of complications and concomitant diseases. Materials and methods: COI of Т2DM was performed using the data obtained in Russian multicenter observational, pharmacoepidemiologic cross-sectional study of diabetes care for assessing routine healthcare pattern of T2DM in the Russian Federation (FORSIGHT-Т2DM). Information for each patient was collected from primary medical records and By asking patients to fill out a questionnaire. Total costs were calculated as the sum of direct medical costs (DCm), direct non-medical costs (DCn) and indirect costs (IC). Results: The final analysis included data from 2014 patients with T2DM residing in 45 cities of RF. Total direct medical costs (DCm) of treating Т2DM and its complications and comorbidities amounted to 105 337 rubles ($2742) per patient per year; direct non-medical costs (DCn) amounted to 24 518 rubles ($638) per patient per year; indirect costs (IC) amounted to 149 754 rubles ($3898) per patient per year. The total cost of T2DM in RF in 2014 year amounted to 279 609 rubles ($7278) per patient. The total cost of T2DM in RF in 2014 amounted to 279 609 rubles per patient. Conclusions: More than half (53,5%) of the total cost of T2DM is the loss of GDP due to patients’ disability. The DCm constitute 37,7% of the total cost of the disease, of which 57% is spent on treatment of T2DM complications and concomitant diseases, while only 10% is spent on glucose-lowering therapies.Ivan I. DedovMarina F. KalashnikovaDmitriy Y. BelousovAleksey S. KolbinVladimir V. RafalskiyAleksey E. CheberdaMariya A. KantemirovaVadim D. ZakievValentin V. FadeyevEndocrinology Research Centrearticletype 2 diabetes mellituspharmacoepidemiologyanalysiscost of illnessdirect medical costsdirect non-medical costsindirect costsNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 20, Iss 6, Pp 403-419 (2017)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	type 2 diabetes mellitus pharmacoepidemiology analysis cost of illness direct medical costs direct non-medical costs indirect costs Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	type 2 diabetes mellitus pharmacoepidemiology analysis cost of illness direct medical costs direct non-medical costs indirect costs Nutritional diseases. Deficiency diseases RC620-627 Ivan I. Dedov Marina F. Kalashnikova Dmitriy Y. Belousov Aleksey S. Kolbin Vladimir V. Rafalskiy Aleksey E. Cheberda Mariya A. Kantemirova Vadim D. Zakiev Valentin V. Fadeyev Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM)
description	Background: Cost-of-Illness Analysis (COI) constitutes the basis for the decision-making process on the budget and allocation in a modern health care system. Considering the wide prevalence of type 2 diabetes mellitus (Т2DM), it is important to perform COI in the Russian Federation (RF). Aim: The aim of the secondary objective FORSIGHT-Т2DM study was to conduct Cost-of-Illness Analysis (COI) of Т2DM in the Russian Federation in relation to taking into consideration the presence of complications and concomitant diseases. Materials and methods: COI of Т2DM was performed using the data obtained in Russian multicenter observational, pharmacoepidemiologic cross-sectional study of diabetes care for assessing routine healthcare pattern of T2DM in the Russian Federation (FORSIGHT-Т2DM). Information for each patient was collected from primary medical records and By asking patients to fill out a questionnaire. Total costs were calculated as the sum of direct medical costs (DCm), direct non-medical costs (DCn) and indirect costs (IC). Results: The final analysis included data from 2014 patients with T2DM residing in 45 cities of RF. Total direct medical costs (DCm) of treating Т2DM and its complications and comorbidities amounted to 105 337 rubles ($2742) per patient per year; direct non-medical costs (DCn) amounted to 24 518 rubles ($638) per patient per year; indirect costs (IC) amounted to 149 754 rubles ($3898) per patient per year. The total cost of T2DM in RF in 2014 year amounted to 279 609 rubles ($7278) per patient. The total cost of T2DM in RF in 2014 amounted to 279 609 rubles per patient. Conclusions: More than half (53,5%) of the total cost of T2DM is the loss of GDP due to patients’ disability. The DCm constitute 37,7% of the total cost of the disease, of which 57% is spent on treatment of T2DM complications and concomitant diseases, while only 10% is spent on glucose-lowering therapies.
format	article
author	Ivan I. Dedov Marina F. Kalashnikova Dmitriy Y. Belousov Aleksey S. Kolbin Vladimir V. Rafalskiy Aleksey E. Cheberda Mariya A. Kantemirova Vadim D. Zakiev Valentin V. Fadeyev
author_facet	Ivan I. Dedov Marina F. Kalashnikova Dmitriy Y. Belousov Aleksey S. Kolbin Vladimir V. Rafalskiy Aleksey E. Cheberda Mariya A. Kantemirova Vadim D. Zakiev Valentin V. Fadeyev
author_sort	Ivan I. Dedov
title	Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM)
title_short	Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM)
title_full	Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM)
title_fullStr	Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM)
title_full_unstemmed	Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM)
title_sort	cost-of-illness analysis of type 2 diabetes mellitus in the russian federation: results from russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (forsight-т2dm)
publisher	Endocrinology Research Centre
publishDate	2017
url	https://doaj.org/article/539c7cdef59a4e00acef6e429a6d993f
work_keys_str_mv	AT ivanidedov costofillnessanalysisoftype2diabetesmellitusintherussianfederationresultsfromrussianmulticenterobservationalpharmacoepidemiologicstudyofdiabetescareforpatientswithtype2diabetesmellitusforsightt2dm AT marinafkalashnikova costofillnessanalysisoftype2diabetesmellitusintherussianfederationresultsfromrussianmulticenterobservationalpharmacoepidemiologicstudyofdiabetescareforpatientswithtype2diabetesmellitusforsightt2dm AT dmitriyybelousov costofillnessanalysisoftype2diabetesmellitusintherussianfederationresultsfromrussianmulticenterobservationalpharmacoepidemiologicstudyofdiabetescareforpatientswithtype2diabetesmellitusforsightt2dm AT alekseyskolbin costofillnessanalysisoftype2diabetesmellitusintherussianfederationresultsfromrussianmulticenterobservationalpharmacoepidemiologicstudyofdiabetescareforpatientswithtype2diabetesmellitusforsightt2dm AT vladimirvrafalskiy costofillnessanalysisoftype2diabetesmellitusintherussianfederationresultsfromrussianmulticenterobservationalpharmacoepidemiologicstudyofdiabetescareforpatientswithtype2diabetesmellitusforsightt2dm AT alekseyecheberda costofillnessanalysisoftype2diabetesmellitusintherussianfederationresultsfromrussianmulticenterobservationalpharmacoepidemiologicstudyofdiabetescareforpatientswithtype2diabetesmellitusforsightt2dm AT mariyaakantemirova costofillnessanalysisoftype2diabetesmellitusintherussianfederationresultsfromrussianmulticenterobservationalpharmacoepidemiologicstudyofdiabetescareforpatientswithtype2diabetesmellitusforsightt2dm AT vadimdzakiev costofillnessanalysisoftype2diabetesmellitusintherussianfederationresultsfromrussianmulticenterobservationalpharmacoepidemiologicstudyofdiabetescareforpatientswithtype2diabetesmellitusforsightt2dm AT valentinvfadeyev costofillnessanalysisoftype2diabetesmellitusintherussianfederationresultsfromrussianmulticenterobservationalpharmacoepidemiologicstudyofdiabetescareforpatientswithtype2diabetesmellitusforsightt2dm
_version_	1718429526998908928

Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM)

Ejemplares similares